Nanion Technologies and Axion Biosystems Announce Strategic Distribution Partnership for Europe and China

Nanion Technologies, a leading provider of automated patch clamp platform and Axion Biosystems, originator of the first high throughput microelectrode array system have announced a distribution partnership in Europe and China. Nanion will immediately carry Axion’s MEA-products, supporting the Muse, a single well MEA system and the Maestro multi-well system with HTS capabilities.

Dr. Niels Fertig, CEO and founder of Nanion Technologies, said: “We are extremely impressed by Axion’s MEA-systems because of their broad scope of applications, ranging from in-depth, highly resolved cellular network behaviour to high throughput drug screening. We think that Axions’s products provide an excellent complement to our automated patch clamp screening and impedance-based systems, and see great potential for applications including phenotype screening, stem cells as tools for phenotypic disease models, and of course, safety, neuro- and cardiotoxicity testing. "

"Additionally, the partnership with Axion will further strengthen us as the one-stop-shop for proficient tools for electrophysiology drug research, screening and intersecting areas.”

Tom O’Brien, CEO of Axion Biosystems, added: “Nanion is a great match for Axion, since we share the same background and philosophy, ultimately manifested in innovative products. As companies, we both have a solid research- and application-driven focus, as well as a deep understanding and broad expertise in science and technical development. These characteristics are combined with a vision to push the boundaries toward HTS-compatible products. We were attracted to "

Nanion’s strong track record of growth, and their excellent reputation for customer service and product reliability. We are excited about this partnership and have great confidence that Nanion will be very successful as our sales and distribution partner for the European and Chinese markets.”